BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| AS 8351 | AS 8351 has been found to show the activity in inducing reprogramming of human fetal lung fibroblasts into functional cardiomyocytes. Group: Pharmaceutical. CAS No. 796-42-9. Pack Sizes: 50 mg. Product ID: B0084-169914. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Asciminib | Asciminib, also known as ABL-001, is a potent and selective allosteric Bcr-Abl inhibitor. Asciminib inhibits Ba/F3 cell growth with an IC50 of 0.25 nM. Uses: Tyrosine kinase inhibitors. Group: Pharmaceutical. CAS No. 1492952-76-7. Pack Sizes: 10 mg. Product ID: B0084-007699. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asciminib-[15N,d4] | Asciminib-[15N,d4] is the labelled analogue of Asciminib. Asciminib, also known as ABL-001, is a potent and selective allosteric Bcr-Abl inhibitor. Asciminib inhibits Ba/F3 cell growth with an IC50 of 0.25 nM. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: BLP-014882. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ascomycin Impurities | Ascomycin Impurities are significant in biomedical research, offering insights into immunosuppressive drug development. By examining these impurities, scientists can enhance the efficacy and safety of Ascomycin derivatives, which are primarily used to treat conditions such as organ transplant rejection and autoimmune diseases. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ascorbyl Impurities | Ascorbyl Impurities are critical in the quality control of ascorbic acid (vitamin C) formulations. They are analyzed for their impact on the stability and efficacy of vitamin C-based pharmaceuticals. Understanding these impurities aids in enhancing drug efficacy particularly in formulations aimed at treating scurvy and supporting immune health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asenapine Impurities | Asenapine Impurities, acting as essential reference markers, occupy a crucial niche in biomedical endeavors. They ensure the purity, efficacy, and safety of asenapine formulations vital for psychiatric treatments, particularly schizophrenia and bipolar disorder. These impurities aid in drug formulation, highlight regulatory compliance, and unveil synthesis and degradation pathways. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asenapine maleate | Asenapine Maleate is a 5-HT receptor antagonist used for the treatment of acute schizophrenia and bipolar mania. It is a second-generation (atypical) antipsychotic agent. Group: Pharmaceutical. CAS No. 85650-56-2. Pack Sizes: 1 g. Product ID: B0084-007055. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asiatic acid | Asiatic acid is the aglycone of asiaticoside isolated from the plant Centella asiatica, commonly used in wound healing. Asiatic acid has the potential for skin cancer treatment. Asiatic acid also has anti-inflammatory activities. Uses: Antihyperlipidemic. Group: Pharmaceutical. CAS No. 464-92-6. Pack Sizes: 100 mg. Product ID: NP6983. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asiaticoside | Asiaticoside is a natural triterpenoid found in the herbs of Centella asiatica (L.) Urban. Asiaticoside shows anxiolytic-like and antidepressant-like effects. Asiaticoside may be useful for the anti-gastric ulcers and alsocan be used in cosmetic material. Uses: Anti-infective agents. Group: Pharmaceutical. CAS No. 16830-15-2. Pack Sizes: 100 mg. Product ID: NP7234. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asimadoline | Asimadoline is a κ opioid receptor agonist with less brain-penetrant ability. Asimadoline is the potential treatment of irritable bowel syndrome. Group: Pharmaceutical. CAS No. 153205-46-0. Pack Sizes: 50 mg. Product ID: B0084-071264. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asimilobine | Asimilobine is a natural alkaloid compound found in several plants. Group: Pharmaceutical. CAS No. 6871-21-2. Pack Sizes: 1 mg. Product ID: NP0126. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asoxime Impurities | Asoxime impurities, integral to the biomedical sector, underpin research initiatives focused on antidotal advancements for nerve agent toxicity. By elucidating these impurities, researchers enhance the synthesis and purity of asoxime chloride, a critical countermeasure against organophosphate-induced toxicity from chemical warfare agents, thereby advancing therapeutic efficacy and safety standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ASP-9521 | ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3). ASP9521 has demonstrated anti-tumour activity in in vitro and in vivo preclinical models. ASP9521 inhibited conversion of androstenedione (AD) into testosterone (T) by recombinant human or cynomolgus monkey AKR1C3 in a concentration-dependent manner. Group: Pharmaceutical. CAS No. 1126084-37-4. Pack Sizes: 100 mg. Product ID: B0084-462669. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aspartame Impurities | Aspartame Impurities play a crucial role in the biomedical field, ensuring the artificial sweetener's safety and efficacy. Through rigorous impurity analysis, potential toxicological outcomes are monitored, thereby safeguarding product quality and aiding regulatory adherence. This vigilance is vital in pharmacovigilance and comprehensive risk assessment methodologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aspirin Impurities | Aspirin Impurities play a crucial role in the biomedical industry as analytical reference standards for drug purity assessment and quality control. They are essential in identifying potential contaminants, ensuring the efficacy and safety of aspirin, a widely used medication for pain, fever, and inflammation management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aspoxicillin | Aspoxicillin is a semi-synthetic penicillin prepared from 6-aminopenicillanic acid (6-APA) or Amoxicillin. It has a broad antibacterial spectrum and has an effect on Pseudomonas aeruginosa. Group: Pharmaceutical. CAS No. 63358-49-6. Pack Sizes: 100 mg. Product ID: BBF-00569. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astaxanthin | Astaxanthin is a carotenoid pigment found mostly in animal organisms, but also occurring in plants. It is thought to be the precursor of astacin. It is a potent lipid-soluble antioxidant. It has broad application prospects in health products, medicine, cosmetics, food additives and aquaculture. Astaxanthin is a natural antioxidant with the strongest antioxidant and anti-aging ability in nature, and its antioxidant capacity is much higher than VE and β-carotene. It significantly enhances mitochondrial activity required for cell recombination and effectively protects the skin from UVA, UVB and blue light damage. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 472-61-7. Pack Sizes: 10 g. Product ID: BBF-05817. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astaxanthin Impurities | Astaxanthin Impurities, essential in biomedical quality assurance, serve as reference standards crucial in the meticulous control of astaxanthin preparations. Comprehending these impurities is vital for affirming the safety and efficacy of astaxanthin, recognized for its potent antioxidant effects in cardiovascular care and skin health promotion. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astemizole Impurities | Astemizole Impurities hold substantial importance in pharmaceutical research, facilitating the evaluation of astemizole's purity and safety—a key antihistamine for allergic rhinitis and chronic urticaria treatment. The precise detection and identification of these impurities are vital for guaranteeing therapeutic effectiveness while minimizing adverse reactions, thus ensuring patient safety. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside | Astragaloside is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. It is traditionally prescribed for the prevention and treatment of cerebrovascular diseases. Astragaloside is a natural compound used in cosmetics material. Group: Pharmaceutical. CAS No. 17429-69-5. Pack Sizes: 50 mg. Product ID: B0005-465162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside A | Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the treatment of cardiovascular diseases. Group: Pharmaceutical. CAS No. 83207-58-3. Pack Sizes: 10 mg. Product ID: B0084-078109. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside I | Astragaloside I is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. Astragaloside I has cardioprotective effects as well as causing improvement in cognitive function. It has anti-gastric effect. It has been shown to increase gastric pH without changing gastric volume or acid output. Uses: Astragaloside i has cardioprotective effects as well as causing improvement in cognitive function. it has anti-gastric effect and could increase gastric ph without changing gastric volume or acid output. Group: Pharmaceutical. CAS No. 84680-75-1. Pack Sizes: 20 mg. Product ID: B0005-464358. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside II | Astragaloside II is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. Astragaloside II has cardioprotective effects as well as causing improvement in cognitive function. It is used in the prevention of cardio-cerebral vascular diseases. It stimulates osteoblast differentiation resulting in bone formation. It exhibits a significant induction of proliferation, differentiation and mineralization in primary osteoblasts. It is a potent MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Uses: Astragaloside ii has cardioprotective effects as well as causing improvement in cognitive function. it is used in the prevention of cardio-cerebral vascular diseases. it may be used as a potential adjunctive agent for hepatic cancer chemotherapy. Group: Pharmaceutical. CAS No. 84676-89-1. Pack Sizes: 20 mg. Product ID: NP7020. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside III | Astragaloside III is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. Uses: Astragaloside iii has cardioprotective effects as well as causing improvement in cognitive function. it is ued in the prevention of cardio-cerebral vascular diseases. it is an antioxidant. Group: Pharmaceutical. CAS No. 84687-42-3. Pack Sizes: 20 mg. Product ID: NP7026. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Astragaloside IV | Astragaloside IV is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. It has anti-aging properties, antioxidant, anti-inflammatory and anti-fibrotic effects in systemic sclerosis. It inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Astragaloside IV is a natural compound used in cosmetics material. Uses: Cardiovascular protection. Group: Pharmaceutical. CAS No. 84687-43-4. Pack Sizes: 50 mg. Product ID: NP6997. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Asunaprevir | Asunaprevir is a potent hepatitis C virus (HCV) non-structural protein protease inhibitor currently in Phase III clinical trials for the treatment of HCV infection. Uses: Protease inhibitors. Group: Pharmaceutical. CAS No. 630420-16-5. Pack Sizes: 50 mg. Product ID: B0084-463296. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AT13148 | AT13148 is an orally available multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. It can block phosphorylation of AKT, p70S6K, PKA, ROCK and SGK substrates, and induce apoptosis in cancer cells. Group: Pharmaceutical. CAS No. 1056901-62-2. Pack Sizes: 50 mg. Product ID: B0084-462670. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AT-265 | AT-265 is a nucleoside antibiotic produced by Streptomyces rishiensis. It has anti-gram-positive and negative bacteria activity. Group: Pharmaceutical. CAS No. 66522-52-9. Pack Sizes: 5 mg. Product ID: BBF-03211. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AT-406 | AT-406 is a potent Smac mimetic and an antagonist of IAP (inhibitor of apoptosis protein via E3 ubiquitin ligase), binding to XIAP-BIR3 (with Ki of 66.4 nM), cIAP1-BIR3(with Ki of 1.9 nM) and cIAP2-BIR3 (with Ki of 5.1 nM), respectively. Group: Pharmaceutical. CAS No. 1071992-99-8. Pack Sizes: 100 mg. Product ID: B0084-454116. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AT7519 HCl | AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. Group: Pharmaceutical. CAS No. 902135-91-5. Pack Sizes: 10 mg. Product ID: B0084-100271. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AT9283 | AT-9283 is a broad spectrum kinase inhibitor that potently inhibits Aurora A, Aurora B, JAK2, JAK3, and c-ABL (IC50= 3, 3, 1.2, 1.1, and 4 nM, respectively). It also potently (IC50 = <1 μM) inhibits serine/threonine kinases as well as receptor and non-receptor tyrosine kinases. Group: Pharmaceutical. CAS No. 896466-04-9. Pack Sizes: 10 mg. Product ID: B0084-100114. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ataluren Impurities | Ataluren Impurities, crucial in the pharmaceutical industry, facilitate the quality control and safety evaluation of Ataluren, a drug designed to treat genetic disorders like Duchenne muscular dystrophy. By assessing impurities, researchers ensure drug efficacy and compliance, contributing significantly to therapeutic advancements and patient health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atazanavir | Atazanavir is a novel and potent azapeptide protease inhibitor that specifically inhibits the human immunodeficiency virus type 1 (HIV-1) protease enzyme with inhibition constant Ki of 66 nmol/L and also inhibits the viral replication of HIV-1 with 50% effective concentration EC50 ranging from 2.6 to 5.3 nmol/L. Atazanavir binds to HIV-1 protease preventing the cleavage of gag and gag-pol polyproteins, which results in the formation of immature virions in HIV-1-infected cells. Atazanavir has a different C-2 symmetric chemical structure and a generally greater antiretroviral potency in various HIV strains compared to other protease inhibitors, including indinavir, nelfinavir, ritonavir, saquinavir and amprenavir. Group: Pharmaceutical. CAS No. 198904-31-3. Pack Sizes: 1 g. Product ID: B0084-062263. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atazanavir Impurities | Atazanavir Impurities, crucial in the biomedical industry, are vital for the quality control and development of the antiretroviral drug Atazanavir, used in treating HIV/AIDS. These impurities help in understanding the drugs stability, efficacy, and safety, ensuring a high standard in pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ATB 346 | ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity. Group: Pharmaceutical. CAS No. 1226895-20-0. Pack Sizes: 50 mg. Product ID: B0084-457689. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atenolol Impurities | Atenolol Impurities encompass the by-products and degradation substances associated with the beta-blocker atenolol, integral to quality control within pharmaceutical manufacturing. These impurities play a crucial role in validating atenolol's safety and efficacy, a medication predominantly prescribed for hypertension management and cardiovascular risk mitigation. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ATI-2341 | A potent and functionally selective allosteric agonist of CXCR4. Group: Pharmaceutical. CAS No. 1337878-62-2. Pack Sizes: 5 mg. Product ID: BAT-006087. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atipamezole | Atipamezole, a 4-substituted imidazole derivative, is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate. Uses: Atipamezole is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate. Group: Pharmaceutical. CAS No. 104054-27-5. Pack Sizes: 100 mg. Product ID: B0084-081151. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atipamezole Hydrochloride | The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate. Uses: The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate. Group: Pharmaceutical. CAS No. 104075-48-1. Pack Sizes: 100 mg. Product ID: B2693-081153. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atipamezole Impurities | Atipamezole Impurities, identified in the quality control of atipamezole formulations, are crucial in ensuring drug purity and safety. Atipamezole, an alpha-2 adrenergic antagonist, is used predominantly for reversing anesthesia in veterinary medicine. Monitoring these impurities is vital for mitigating adverse effects and optimizing therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atomoxetine Impurities | Atomoxetine Impurities occupy a critical niche in pharmaceutical scrutiny, profoundly influencing the evaluation and refinement of Atomoxetines potency, safety profile, and purity for ADHD treatment. These impurities are pivotal in advancing analytical techniques and solidifying drug formulation frameworks, thereby fostering pharmaceutical innovation and ensuring medicinal reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin 3-Deoxyhept-2E-Enoic Acid (Calcium Salt) | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-466961. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Group: Pharmaceutical. CAS No. 1315629-79-8. Pack Sizes: 1 mg. Product ID: B2694-067641. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Group: Pharmaceutical. CAS No. 1316291-19-6. Pack Sizes: 2.5 mg. Product ID: B1370-008834. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin EP Impurity D | Atorvastatin EP Impurity D is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. CAS No. 148146-51-4. Pack Sizes: 25 mg. Product ID: B2694-466943. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Epoxy Tetrahydrofuran Impurity | Atorvastatin Epoxy Tetrahydrofuran Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. CAS No. 873950-19-7. Pack Sizes: 1 mg. Product ID: B0190-466978. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Ethyl Ester | Atorvastatin Ethyl Ester is the impuritiy of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Group: Pharmaceutical. CAS No. 1146977-93-6. Pack Sizes: 25 mg. Product ID: B2694-466959. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Impurities | Atorvastatin Impurities play a crucial role in the biomedical industry by facilitating the assessment of atorvastatin's purity and stability. These impurities are vital for developing and optimizing formulations used in hypercholesterolemia treatments, ensuring safety and efficacy in lowering cholesterol levels to prevent cardiovascular diseases. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Lactam Sodium Salt Impurity | Atorvastatin Lactam Sodium Salt Impurity is a photodegradation product of Atorvastatin. It is a cyclic impurity of Atorvastatin. Group: Pharmaceutical. CAS No. 148217-40-7. Pack Sizes: 5 mg. Product ID: B2694-466956. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Methyl Ester | Atorvastatin Methyl Ester is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. CAS No. 345891-62-5. Pack Sizes: 50 mg. Product ID: B0190-466944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide | Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide is a prominent compound in the research of dyslipidemia and associated cardiovascular disorders. Its efficacious mechanism of action lies in its tremendous capacity to inhibit HMG-CoA reductase, a pivotal enzyme profoundly engaged in the intricate process of cholesterol biosynthesis. Uses: Atorvastatin (a791750) impurity. Group: Pharmaceutical. CAS No. 1105067-87-5. Pack Sizes: 10 mg. Product ID: B0190-258830. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound A | Atorvastatin USP Related Compound A is an impurity in the synthesis of Atorvastatin, which is a competitive HMG-CoA reductase inhibitor. Atorvastatin is a lipid-lowering medication of the statin class. Atorvastatin suppresses the production of cholesterol and prevents some cardiovascular diseases. Group: Pharmaceutical. CAS No. 433289-83-9. Pack Sizes: 100 mg. Product ID: B0190-168852. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound B calcium salt | Atorvastatin USP Related Compound B is an impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Group: Pharmaceutical. CAS No. 887196-25-0. Pack Sizes: 10 mg. Product ID: B2694-168853. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound C | Atorvastatin USP Related Compound C is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. CAS No. 693793-53-2. Pack Sizes: 10 mg. Product ID: B2694-168854. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound E | Atorvastatin USP Related Compound E is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. CAS No. 1105067-88-6. Pack Sizes: 5 mg. Product ID: B0190-466957. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atosiban | Atosiban, a nonapeptide, desamino-oxytocin analogue, is a competitive inhibitor of the hormones oxytocin and vasopressinv. It inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. It antagonises uterine contractions and induces uterine quiescence in human pre-term labour at the recommended dosage. It was developed by Ferring Pharmaceuticals in Sweden. It is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women. Uses: Atosiban is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Group: Pharmaceutical. CAS No. 90779-69-4. Pack Sizes: 10 mg. Product ID: BAT-010038. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atosiban Impurities | Atosiban Impurities, fundamental to the biomedical realm, act as critical benchmarks for evaluating and synthesizing Atosiban, a drug used in managing preterm labor. By confirming purity and potency, these impurities significantly enhance therapeutic safety against early uterine contractions, thereby ensuring maternal-fetal welfare. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atovaquone Impurities | Atovaquone Impurities are fundamental to the pharmaceutical sector's quality assurance, playing a vital role in verifying the purity and safety of atovaquone, a medication targeting malaria and pneumocystis. They underpin the creation of sophisticated analytical techniques, ensuring vigilance over degradation byproducts in atovaquone preparations, thus enhancing therapeutic efficacy and stability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atpenin A5 | Atpenin A5 is an inhibitor of SDHB, SDHC and SDHD. It is an antifungal antibiotic produced by Penicillium sp. and an ubiquinone-binding site inhibitor of succinate dehydrogenase with IC50s of 12 nM for nematode and IC50s of 3.7 nM for mammalian mitochondria. Atpenin A5 is the most effective inhibitor against complex II from all the atpenins and has been shown to protect against cardiac-reperfusion injury in rat studies through the stimulation of mitochondrial KATP channels. Group: Pharmaceutical. CAS No. 119509-24-9. Pack Sizes: 50 mg. Product ID: BBF-04652. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atractylenolide I | Atractylenolide I is a sesquiterpenoid found in the rhizome of Atractylodes macrocephala. Atractylenolide I ameliorates sepsis syndrome by reduction of pro-inflammatory cytokines and LPS, and provides an improvement in liver and kidney functions. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 73069-13-3. Pack Sizes: 10 mg. Product ID: NP6004. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atractylodin | Atractylodin is an active component of the essential oil contained in the rhizomes of Atractylodes lancea and A. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 55290-63-6. Pack Sizes: 25 mg. Product ID: NP4273. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atractyloside potassium salt | Atractyloside potassium salt is the potassium salt of atractyloside, which inhibits oxidative phosphorylation by blocking the transfer of adenosine nucleotides through the mitochondrial membrane. Uses: Inhibitor of the adenine nucleotide translocator (ant). Group: Pharmaceutical. CAS No. 102130-43-8. Pack Sizes: 20 mg. Product ID: B0005-158965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atracurium Besilate Impurities | Atracurium Besilate Impurities, integral to the biomedical sphere, play an indispensable role in ensuring quality control and safety assessments of muscle relaxants. Their presence guarantees the accuracy of analytical techniques in the production of Atracurium Besilate, a key neuromuscular-blocking agent utilized in surgical procedures for muscle relaxation induction. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atracurium Besylate EP impurity B (Oxalate Salt) | Atracurium Besylate EP impurity B (Oxalate Salt) is an impurity of Atracurium Besylate, a neuromuscular blocking agent used during surgeries and for mechanical ventilation. Group: Pharmaceutical. CAS No. 96687-52-4. Pack Sizes: 100 mg. Product ID: B0371-336184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atranorin | Atranorin, which can be found in the herbs of Parmelia tinctorum Despr, has a relevant redox-active action, acting as a pro-oxidant or antioxidant agent depending on the radical. Also, it will exert cytoprotective effects on cells under oxidative stress induced by H(2)O(2). It was found to be more efficient at equitoxic doses and correlated more strongly with an increased number of floating cells or a higher apoptotic index. It also exhibited significant anti-inflammatory activity in the acute model of inflammation (leukocyte migration to the peritoneal cavity), carrageenan- and arachidonic acid-induced hind paw edema in rats. Besides, Atranorin exhibited a dose-dependent antioxidant activity in vitro, as assessed by total radical-trapping antioxidant parameter and total antioxidant reactivity assays. Uses: Antinociceptive / antiinflammatory / antibacterial. Group: Pharmaceutical. CAS No. 479-20-9. Pack Sizes: 100 mg. Product ID: NP4582. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atropine Impurities | Atropine Impurities, integral to pharmaceutical examination, underpin the assessment of atropine formulation purity and stability. Their comprehension fortifies therapeutic applications, pivotal in addressing bradycardia and organophosphate poisoning, thereby ensuring clinical effectiveness and safeguarding medical practices. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AtuFECT01 | AtuFect01 is part of the lipid system AtuPLEX and shows more effective siRNA binding activity and delivery to vascular endothelial cells. Group: Pharmaceutical. CAS No. 869094-19-9. Pack Sizes: 10 mg. Product ID: BRH-016. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Auranofin | Auranofin appears to induce heme oxygenase 1 (HO-1) mRNA, as an inhibitor of thioredoxin reductase (TrxR) (IC50 = 20 nM; Ki = 4 nM for the NADPH-reduced form of human cytosolic TrxR). Uses: Auranofin inhibits various leukocyte activation pathways at multiple sites. Group: Pharmaceutical. CAS No. 34031-32-8. Pack Sizes: 1 g. Product ID: B2693-397760. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Auraptenol | Auraptenol is a natural coumarin found in the fruits of Citrus aurantium. It has antifibrotic activity and the anti-hyperalgesic action which may be as a novel analgesic for the management of neuropathic pain. Uses: Antifibrotic, anti-hyperalgesic. Group: Pharmaceutical. CAS No. 1221-43-8. Pack Sizes: 5 mg. Product ID: NP1176. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aureobasidin A | Aureobasidin A is a cyclic depsipeptide antibiotic isolated from the filamentous fungus Aureobasidium pullulans R106. It is an antifungal agent that inhibits phosphorylceramide synthase. Group: Pharmaceutical. CAS No. 127785-64-2. Pack Sizes: 1 mg. Product ID: BBF-04146. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.